gemcitabine has been researched along with transferrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, A; Ishigaki, Y; Motoo, Y; Shimasaki, T; Takata, T; Tomosugi, N; Tsuchida, H | 1 |
| DeVaux, RS; Espinal, R; Hepel, M; Herschkowitz, JI; Kurzatkowska, K; Santiago, T | 1 |
| Leblanc, RM; Pardo, J; Peng, Z | 1 |
| Al-Youbi, AO; Bashammakh, AS; El-Shahawi, MS; Graham, RM; Leblanc, RM; Liyanage, PY; Vanni, S; Zhou, Y | 1 |
1 review(s) available for gemcitabine and transferrin
| Article | Year |
|---|---|
Cancer Targeting and Drug Delivery Using Carbon-Based Quantum Dots and Nanotubes.
Topics: Antineoplastic Agents; Deoxycytidine; Doxorubicin; Drug Carriers; Drug Liberation; Fluorescent Dyes; Folic Acid; Gemcitabine; Humans; Hyaluronic Acid; Molecular Targeted Therapy; Nanotubes, Carbon; Neoplasms; Quantum Dots; Surface Properties; Transferrin | 2018 |
3 other study(ies) available for gemcitabine and transferrin
| Article | Year |
|---|---|
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.
Topics: 14-3-3 Proteins; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Humans; Lactoferrin; Neoplasm Proteins; Pancreatic Neoplasms; Proteomics; S100 Proteins; Transferrin | 2012 |
Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine.
Topics: Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Deoxycytidine; Doxorubicin; Drug Delivery Systems; Female; Folic Acid; Gemcitabine; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Molecular Targeted Therapy; Spectrum Analysis, Raman; Transferrin; Triple Negative Breast Neoplasms | 2017 |
Pediatric glioblastoma target-specific efficient delivery of gemcitabine across the blood-brain barrier via carbon nitride dots.
Topics: Animals; Antimetabolites, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Cell Line; Cell Survival; Deoxycytidine; Drug Carriers; Gemcitabine; Glioblastoma; Humans; Larva; Nitriles; Quantum Dots; Transferrin; Zebrafish | 2020 |